Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome

Bone Marrow Transplantation

Volumn 41, Issue 2, 2008, Pages 127-132

  Gluckman, E ^a   Wagner, J E ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUSULFAN; BUTADIENE DIEPOXIDE; CLASTOGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FANCONI ANEMIA GROUP D2 PROTEIN; FLUDARABINE; HLA ANTIGEN; MITOMYCIN C; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITROGEN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE 4; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLACKFAN DIAMOND ANEMIA; BLOOD ANALYSIS; BLOOD TOXICITY; BLOOD TRANSFUSION; BONE MARROW BIOPSY; BONE MARROW DEPRESSION; BONE MARROW EXAMINATION; CHROMOSOME ANALYSIS; CLINICAL FEATURE; CONGENITAL DISORDER; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR SELECTION; DYSKERATOSIS CONGENITA; ENZYME DEFICIENCY; FANCONI ANEMIA; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; KOSTMANN SYNDROME; LOW DRUG DOSE; LYMPH NODE IRRADIATION; MALIGNANT TRANSFORMATION; MONOZYGOTIC TWINS; MORTALITY; NIJMEGEN BREAKAGE SYNDROME; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PEARSON SYNDROME; PERIPHERAL LYMPHOCYTE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE 4 DEFICIENCY; PRIORITY JOURNAL; REVIEW; SECKEL SYNDROME; SHWACHMAN SYNDROME; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA;

ANEMIA, HYPOPLASTIC, CONGENITAL; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MYELOABLATIVE AGONISTS; SIBLING RELATIONS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 38849178108     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705960     Document Type: Review

References (17)

1. Shimamura A. Inherited bone marrow failure syndrome: Molecular features. Hematol Am Soc Hematol Educ Program 2006; 65-71.
2. Taniguchi T, D'Andrea AD. Molecular pathogenesis of Fanconi anemia: recent progress. Blood 2006; 107: 4223-4233.
3. Guardiola P, Socie G, Li X, Ribaud P, Devergie A, Esperou H et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: Risk factors and influence on outcome. Blood 2004; 103: 73-77.
4. Socie G, Devergie A, Girinski T, Piel G, Ribaud P, Esperou H et al Transplantation for Fanconi's anaemia: Long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol 1998; 103: 249-255.
5. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003; 101: 822-826.
6. Deeg HJ, Socie G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A et al. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients. Blood 1996; 87: 386-392.
7. Tan PL, Wagner JE, Auerbach AD, Defor TE, Slungaard A, Macmillan ML. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients under-going genotypically identical donor hematopoietic cell transplantation. Pediatr Blood Cancer 2006; 46: 630-636.
8. Guardiola P, Pasquini R, Dokal I, Ortega JJ, van Weel-Sipman M, Marsh JC et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: A study on behalf of the European Group for Blood and Marrow Transplantation. Blood 2000; 95: 422-429.
9. Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007; 109: 2256-2262.
10. Gluckman E, Rocha V, Ionescu I, Bierings M, Harris RE, Wagner J et al Results of unrelated cord blood transplant in Fanconi anemia patients: Risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 2007; 13: 1073-1082.
11. Grewal SS, Kahn JP, MacMillan ML, Ramsay NK, Wagner JE. Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis. Blood 2004; 103: 1147-1151.
12. Rocha V, Devergie A, Socie G, Ribaud P, Esperou H, Parquet N et al Unusual complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol 1998; 103: 243-248.
13. Dror Y, Freedman MH. Shwachman-Diamond syndrome. Br J Haematol 2002; 118: 701-713.
14. Roy V, Perez WS, Eapen M, Marsh JC, Pasquini M, Pasquini R et al. Bone marrow transplantation for Diamond-Blackfan anemia. Biol Blood Marrow Transplant 2005; 11: 600-608.
15. Zeidler C, Welte K, Barak Y, Barriga F, Bolyard AA, Boxer L et al. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 2000; 95: 1195-1198.
16. New HV, Cale CM, Tischkowitz M, Jones A, Telfer P, Veys P et al. Nijmegen breakage syndrome diagnosed as Fanconi anaemia. Pediatr Blood Cancer 2005; 44: 494-499.
17. Gruhn B, Seidel J, Zintl F, Varon R, Tonnies H, Neitzel H et al. Successful bone marrow transplantation in a patient with DNA ligase IV deficiency and bone marrow failure. Orphanet J Rare Dis 2007; 2 5.